Health Idea Now
Tuesday, 27 November 2018
Roche buys U.S. biotech Jecure in race for liver disease drugs
Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.
from Reuters: Health News https://ift.tt/2raO2HH
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment